Craig V Comiter, PhD
Associate Professor, Department of Urology
Stanford University Medical Center, USA
Dr. Comiter received his undergraduate degree from Harvard College, and his medical degree from Harvard Medical School. He stayed in Boston for his residency, serving as resident in general surgery at the Brigham and Women’s Hospital, and then completed his urology residency at the Harvard Program in Urology. In 1998, Dr. Comiter served as Clinical Instructor and Fellow in Neurourology and Urodynamics at the University of California in Los Angeles.In 1999, Dr. Comiter joined the faculty at the University of Arizona, as Assistant Professor of Urology. In 2003, he was promoted to Associate Professor, and became Chief of the Section of Urology and Residency Program Director. Under his direction, 25% of graduating residents went on to academic fellowship training.Dr. Comiter has been a strong supporter of the SUFU, having presented several abstracts over the past 7 years, and giving several invited lectures during breakout sessions. In addition, he has sponsored several resident presentations at the SUFU and the AUA annual meetings. He was twice the winner of the Joseph F. McCarthy Essay Contest at the Western Section American Urological Association, and has served on the AUA’s Leadership Council, Public Relations Committee, and Young Urologists Committee.Dr. Comiter has published more than 60 peer-reviewed articles and 25 book chapters, focusing on urinary incontinence, post-prostatectomy incontinence, neuromodulation, and pelvic organ prolapse. He has recently moved to Stanford Medical School, where he is serving as Associate Professor of Urology and Associate Professor of Obstetrics and Gynecology, and is Fellowship Director for the AUA/ABOG and SUFU recognized fellowship in Female Pelvic Medicine and Reconstructive Surgery.
Using various animal models of bladder outlet obstruction as a representation of human prostatic disease, I am investigating how intervening with pharmacotherapy, neuromodulation, and other novel therapies may help to reverse the adverse changes in the bladder due to the obstruction.